Topics to be Discussed

Topics
to be Discussed
Chairpersons
Special
Keynote Address: The Cost of Prostate Disease on Society
Over
150 Experts in 16 Various Committees will discuss the following Topics
1
New
Developments in the Pathobiology of Prostate Disease
J.
Schalken (NL).
2
Advances
in Biomarkers for Prostate Disease
R.
Getzenberg (USA)
3
Epidemiology
and Natural History of Prostate Disease
M.
Barry (USA)
4
New
Development in Imaging of the Prostate and Metastatic Sites
M.
Resnick (USA)
5

LUTS:
Etiology and Patient Assessment

P.
Abrams (UK)

6
New
Medical Developments in the Management of LUTS in Adult Men
C.
Chapple (UK)
7
New
Minimally-Invasive and Surgical Developments in the management of BPO
J.
de la Rosette (NL)
8
Prevention
of BPH Outcomes and Clinical Progression
C.
Roehrborn (USA)
9
New
Therapeutic Targets in BPH and LUTS (Research Priorities)
K-E.
Andersson (E)
10
New
Developments in Screening and early Detection for Prostate Cancer
F.
Schroeder (NL)
11 Prostate
Cancer Chemoprevention
P.
Gan (USA)
12 New
Developments in the Treatment of Localized Prostate Cancer
F.
Schroeder (NL)
13 New
Therapeutic Targets and Treatments for Metastatic Prostate Cancer
W.
Nelson (USA)
14 Androgen
Replacement Therapy in Men at Risk for Prostate Disease
C.L
Schulman (Belgium)
15 Prostatitis
and Chronic Pelvic Pain
T.
Schaeffer (USA)
16 Patient’s
Perspectives in Prostate Diseases
T.
Hudson (E)
  History
of Prostatic Diseases
D.
Schultheiss-R. Waldbaum
FRIDAY,
June 24
SATURDAY,
June 25
SUNDAY,
June 26
MONDAY,
June 27